Deferasirox (Exjade®) Significantly Improves Cardiac T2* in Heavily Iron-Overloaded Patients With Β-Thalassemia Major

Annals of Hematology - Germany
doi 10.1007/s00277-009-0838-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search